We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

QNST:NASDAQQuinStreet, Inc. Analysis

Data as of 2026-04-27 - not real-time

$13.03

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

QuinStreet appears markedly undervalued given its fair‑value estimate far exceeds the current trading price, creating a sizable upside potential. The stock trades below both its price‑to‑earnings and price‑to‑book multiples relative to industry averages, while maintaining solid cash levels and minimal debt. Technical indicators are supportive: the short‑term moving average sits above the longer‑term average, the momentum oscillator remains in a neutral‑to‑bullish zone, and the MACD line is above its signal, all accompanied by rising volume. Recent analyst upgrades to a buy rating and a strong consensus target further reinforce the positive outlook. However, the company’s margins are thin and volatility is elevated, which tempers expectations.
The upside is amplified by a favorable forward earnings outlook and a low forward price‑to‑earnings multiple, suggesting earnings growth is being priced in. The balance sheet is strong with ample cash and modest leverage, reducing financial distress risk. Yet, the high historical drawdown and sector‑specific competitive pressures warrant caution. Overall, the fundamentals and technicals align for a bullish stance, but investors should remain mindful of the inherent volatility and margin constraints.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Bullish MACD crossover
  • Price holding above short‑term support
  • Increasing trading volume

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap to discounted cash‑flow estimate
  • Analyst upgrades and strong consensus target
  • Low forward price‑to‑earnings multiple indicating earnings growth pricing

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Robust cash position and low leverage
  • Elevated volatility and historical drawdowns
  • Thin operating margins limiting sustainable growth

Key Metrics & Analysis

Financial Health

Revenue Growth1.90%
Profit Margin5.64%
P/E Ratio12.2
ROE24.05%
ROA3.26%
Debt/Equity3.12
P/B Ratio2.5
Op. Cash Flow$101.2M
Free Cash Flow$74.5M
Industry P/E18.7

Technical Analysis

TrendNeutral
RSI59.5
Support$11.71
Resistance$13.49
MA 20$12.39
MA 50$11.99
MA 200$14.13
MACDBullish
VolumeIncreasing
Fear & Greed Index88.02

Valuation

Fair Value$20.79
Target Price$19.00
Upside/Downside45.82%
GradeUndervalued
TypeValue

Risk Assessment

Beta1.29
Volatility36.34%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.